Animation - Understanding Immunotherapy for Lung Cancer
This animation explains how immunotherapy works for lung cancer. Immunotherapy uses medicine to stimulate the body's immune system to recognize and attack cancer cells. The immunotherapy drugs that are most often used to treat lung cancer are called "checkpoint inhibitors." On the surface of cancer cells there are proteins that “put the brakes” on the immune system. They serve as “checkpoints” that stop the immune system from launching an all-out assault on cancer. Checkpoint inhibitors work by “taking off the brakes” and giving the immune system free rein to release special cells called T cells that attack the cancer. Watch to learn about checkpoint proteins called PD-1, PD-L1, CTLA-4, considerations for combining immunotherapy with chemotherapy, as well as learn about possible side effects of immunotherapy for lung cancer.
Share with family and friends:
Click here to take our SURVEY Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.
This educational activity has been developed by
A Breath of Hope Lung Foundation and Mechanisms in Medicine Inc.
This activity is supported by educational grants from AstraZeneca Pharmaceuticals, Bristol-Myers Squibb Foundation Inc., Bristol-Myers Squibb Grants and Giving, Celgene Corporation, and Genentech.
This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.